DrugDashboards

Psoriasis

Niccolum Sulphuricum, Natrum Bromatum, Zincum Bromatum, Kali Bromatum, Kali Sulphuricum. · NICKEL SULFATE HEXAHYDRATE 3 [hp_X]/237mL; SODIUM BROMIDE 2 [hp_X]/237mL; ZINC BROMIDE 4 [hp_X]/237mL; POTASSIUM BROMIDE 1 [hp_X]/237mL; POTASSIUM SULFATE 4 [hp_X]/237mL · Liquid · Oral · Plymouth Healthcare Products Llc

NDC 61480-0105-03 · 237 mL in 1 BOTTLE · UNAPPROVED HOMEOPATHIC · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Niccolum Sulphuricum, Natrum Bromatum, Zincum Bromatum, Kali Bromatum, Kali Sulphuricum. (Liquid)

LabelerStrengthFirst seenLast seen
Plymouth Healthcare Products LlcNICKEL SULFATE HEXAHYDRATE 3 [hp_X]/237mL; SODIUM BROMIDE 2 [hp_X]/237mL; ZINC BROMIDE 4 [hp_X]/237mL; POTASSIUM BROMIDE 1 [hp_X]/237mL; POTASSIUM SULFATE 4 [hp_X]/237mLAug 26, 2026Sep 2, 2026
Plymouth Healthcare Products LlcNICKEL SULFATE HEXAHYDRATE 3 [hp_X]/237mL; SODIUM BROMIDE 1 [hp_X]/237mL; ZINC BROMIDE 4 [hp_X]/237mL; POTASSIUM BROMIDE 2 [hp_X]/237mL; POTASSIUM SULFATE 4 [hp_X]/237mLJul 22, 2026Aug 19, 2026
Plymouth Healthcare Products LlcNICKEL SULFATE HEXAHYDRATE 3 [hp_X]/237mL; POTASSIUM BROMIDE 1 [hp_X]/237mL; POTASSIUM SULFATE 4 [hp_X]/237mL; SODIUM BROMIDE 2 [hp_X]/237mL; ZINC BROMIDE 4 [hp_X]/237mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Psoriasis — NDC 61480-0105-03," retrieved September 3, 2026, https://drugdashboards.com/drug/61480010503.

Free to cite with attribution — see how the data is put together.